Target Group Wholly Owned Subsidiary Canary Rx Inc. Provides an Update on Construction at 44,000 Square Foot Norfolk County
30 Octubre 2018 - 7:27AM
InvestorsHub NewsWire
Norfolk County, ON -- October 30, 2018 -- InvestorsHub NewsWire
-- Target Group Inc. (OTCQB: CBDY) today announced that its wholly
owned subsidiary, Canary Rx Inc. ("Canary") (the “Company”) is
pleased to provide an update on construction progress at the
Company’s 44,000 square foot Norfolk County cannabis cultivation
facility.
Canary began leasing the Norfolk County site in July of 2014,
and with support from local authorities, construction was initiated
in September of 2017. Since then, extensive demolition and
structural upgrades have been carried out at the site.
Construction remains on schedule for completion in mid-January
2019. Our crews have made significant progress over the summer,
plus the city has finished upgrading the utilities and
infrastructure surrounding the facility. Freezer panels are being
installed on the interior walls, the ceiling will follow shortly,
at which point the individual rooms can be completed. The building
is being equipped with customized HVAC, plumbing, and electrical
services in layers to ensure a deliberate and seamless finish.
Installation of the security systems is underway and fencing around
the facility is complete. Fitting out of the electrical room is in
the final stages, plus the offices and public areas of the facility
are nearing completion.
Once complete, the facility will contain eight separate flower
rooms, equipped with 1,700 lights. Layout has been engineered to
enable a strictly controlled and optimized environment, and weekly
cannabis harvesting. The flower rooms are initially expected to
produce 3,600kg of cannabis per year. The facility will also
include areas for quality testing, extraction, breeding, processing
and packaging of premium cannabis products.
“Canary has come a long way since we first submitted our
application in June 2015. Progress at the facility is increasingly
exciting to watch as construction nears completion. We look forward
to planting our first crops, and then providing a premium cannabis
experience to Canadian consumers,” said Randall MacLeod, President
and CEO of Canary.
About Canary RX Inc.
Canary Rx Inc. (“Canary”) is a final-stage Licensed Producer
(“LP”) applicant, in active review with Health Canada. Situated
in Ontario’s Garden, Norfolk County, Canary lies
nestled amongst the shores of Lake Erie in a vibrant,
agricultural community. The Company’s 44,000 sq. ft. facility is
engineered to meet strict quality control standards and will be
equipped with the latest environmental control technology. Once
complete, it’s expected to produce 3,600kg of cannabis per year.
Canary is currently positioning itself as a premium cannabis
lifestyle brand, with a focus on producing pure, curated, cannabis
products. Our modern, minimalist branding will grow with the
company, and evolving social and political conditions, situating us
to appeal to both medical and recreational consumers.
About Target Group Inc. (OTCQB: CBDY)
Target Group, Inc. is a diversified and vertically integrated
progressive company with focus on both national and international
presence. The Company operates a wholly-owned late stage Canadian
licensed producer regulated under Health Canada’s Access to
Cannabis for Medical Purposes Regulations (ACMPR): Canary RX, which
operates a 44,000 square foot facility located in Norfolk County,
Ontario. The Company has begun structuring multiple international
production and distribution platforms and intends to continue
rapidly expanding its global footprint as it focuses on building an
iconic brand portfolio whose focus aims at developing cutting edge
Intellectual Property among the medical and recreational cannabis
markets. Target Group is committed to building industry-leading
companies that transform the perception of cannabis and responsibly
elevate the overall consumer
experience. www.targetgroupinc.ca
Forward-Looking Statements
Disclaimer: This press release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. In some cases, you can
identify forward-looking statements by the following words:
"anticipate," "believe," "continue," "could," "estimate," "expect,"
"intend," "may," "ongoing," "plan," "potential," "predict,"
"project," "should," "will," "would," or the negative of these
terms or other comparable terminology, although not all
forward-looking statements contain these words. Forward-looking
statements are not a guarantee of future performance or results,
and will not necessarily be accurate indications of the times at,
or by, which such performance or results will be achieved.
Forward-looking statements are based on information available at
the time the statements are made and involve known and unknown
risks, uncertainties and other factors that may cause our results,
levels of activity, performance or achievements to be materially
different from the information expressed or implied by the
forward-looking statements in this press release. This press
release should be considered in light of all filings of the Company
that are contained in the Edgar Archives of the Securities and
Exchange Commission at www.sec.gov.
Target Group Inc.CEO Rubin Schindermann mob. 647-927-464455 Administration Road, Unit 8 Vaughan, Ontario, Canada L4K-4G9
Target (PK) (USOTC:CBDY)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Target (PK) (USOTC:CBDY)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024